TABLE 1.
General overview of pathology quality control characteristics in our cohort (N = 931) divided by baseline (N = 608) and post-treatment (N = 323) core needle biopsies.
| Biopsy timepoint | Status | N | Characteristic of the sample, median percentage | |||
|---|---|---|---|---|---|---|
| Tumor area | Malignant cells | Fibrosis | Necrosis | |||
| Baseline | Included | 547 | 95 | 60 | 20 | 10 |
| Excluded | 61 | 0 | 0 | 90 | 5 | |
| Post-treatment | Included | 261 | 20 | 50 | 25 | 25 |
| Excluded | 62 | 10 | 5 | 10 | 90 | |